Data from: Head-to-head drug comparisons in multiple sclerosis: urgent action needed

负责人：

关键词：

Multiple Sclerosis;Clinical trials Methodology\/study design;Clinical Trials; 21 Clinical trials Methodology\/study design; 41 Multiple sclerosis; 19 All Clinical trials

DOI：

doi:10.5061/dryad.h5g7nt7

摘要：

Disease-modifying drugs are changing the natural history of multiple sclerosis (MS). However, currently available clinical trial data ar

Data from: Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis

负责人：

关键词：

14 All Clinical Neurology 41 Multiple sclerosis 54 Cohort studies; 58 Natural history studies (prognosis);Neurofilament light chain

DOI：

doi:10.5061/dryad.msbcc2ftm

摘要：

ores of 3.0, 4.0 and 6.0 and conversion to secondary progressive (SP) MS. Results: The median (interquartile range) pNfL was 7.5 (4.1) pg/ml in controls and 11.4 (9.6) pg/ml in MS